Indexed In : Science Citation Index Expanded(SCIE), MEDLINE,
Pubmed/Pubmed Central, Elsevier Bibliographic, Google Scholar,
Databases(Scopus & Embase), KCI, KoreaMed, DOAJ
Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE
Yong Chan Lee |
Professor of Medicine Director, Gastrointestinal Research Laboratory Veterans Affairs Medical Center, Univ. California San Francisco San Francisco, USA |
Jong Pil Im | Seoul National University College of Medicine, Seoul, Korea |
Robert S. Bresalier | University of Texas M. D. Anderson Cancer Center, Houston, USA |
Steven H. Itzkowitz | Mount Sinai Medical Center, NY, USA |
All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.
The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.
Aleksandra Sałagacka, Marta ?ebrowska, Agnieszka Jele?, Marek Mirowski, and Ewa Balcerczak
Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry, Medical University of Lodz, Lodz, Poland
Correspondence to: Aleksandra Sałagacka, Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland, Tel: +48-42-677-91-30, Fax: +48-42-677-91-30, E-mail: aleksandra.salagacka@umed.lodz.pl
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gut Liver 2014;8(6):632-636. https://doi.org/10.5009/gnl13224
Published online November 1, 2014, Published date November 29, 2014
Copyright © Gut and Liver.
Tumor necrosis factor α (TNF-α) encoded by
Gastric mucosa specimens obtained from 177 Polish peptic ulcer patients were used to conduct rapid urease tests and to assess the investigated polymorphisms by polymerase chain reaction-restriction fragment length polymorphism. Genotyping data were compared with the results obtained from healthy individuals of Polish origin.
There were no significant differences in genotype and allele frequency of the investigated polymorphisms between peptic ulcer patients and healthy individuals. No associations between the frequencies of particular genotypes and alleles for both single-nucleotide polymorphisms (SNPs) and the presence of
The investigated SNPs are not risk factors for either peptic ulcer or
Keywords: Tumor necrosis factor-alpha, Genetic polymorphism, Peptic ulcer, Restriction fragment length polymorphism
Considering the vital role of TNF-α in the pathogenesis of PUD, it is reasonable to expect that genetic polymorphisms influencing the
The investigation was in accordance with the principles of the Declaration of Helsinki and was approved by the Ethical Committee of Medical University of Lodz. One hundred seventy-seven unrelated outpatients (111 females: median age 53 years, range 14 to 85 years; 66 males: median age 55 years, range 20 to 84 years) who visited the Department of Surgery, District Hospital, Łęczyca, Poland for an gastroduodenoscopy because of dyspepsia and diagnosed as peptic ulcer were enrolled in the study. Presence of
Genotyping of -308G>A and -1031T>C
Statistical analysis were performed using the STATISTICA version 10 (StatSoft Inc., Tulsa, OK, USA) software package. The chi-square test was applied to evaluate conformity between the observed and expected genotype frequencies according to the Hardy-Weinberg rule and to determine the significance of differences in allele and genotype frequencies between the patients and controls. An odds ratio with a 95% confidence interval was estimated by logistic regression. A p-value <0.05 was assumed as significant in all the conducted tests.
All 177 gastric mucosa biopsy specimens were successfully analysed for polymorphisms at positions -308 and -1031 of
All the genotypes for both polymorphisms were distributed in accordance with Hardy-Weinberg equilibrium within both patient and control cohorts which confirmed the cohorts as suitable. Genotype and allele frequencies occurred with similar frequencies in peptic ulcer and control groups for both -308G>A and -1031T>C SNPs. No statistically significant differences between investigated and control group were found (
According to the results of rapid urease tests, peptic ulcer patients were divided into two groups:
Host response to
The present study evaluated the effect of
There was no association between occurrence of peptic ulcer and any of investigated polymorphisms. This finding is in agreement with some of previously published results for peptic ulcer patients. No association was stated between PUD incidence and -308G>A
Also, there was no connection between any of investigated SNPs and
Recently, we showed that 3435C>T polymorphism of the
Some researchers postulate the
In conclusion, neither -308G>T nor -1031T>C SNP is a factor for genetic susceptibility to peptic ulcer in the population. Moreover, none of the investigated SNPs are the risk factors for
Comparison of the
Peptic ulcer case (n=177) | Healthy individual (n=248) | p-value | OR | 95% CI | |
---|---|---|---|---|---|
GG | 121 (68.4) | 172 (69.4) | 0.8775 | 1.00 | - |
GA | 54 (30.5) | 72 (29.0) | 1.02 | 0.98–1.53 | |
AA | 2 (1.1) | 4 (1.6) | 1.04 | 0.46–2.35 | |
G | 296 (83.6) | 416 (83.9) | 0.9208 | - | - |
A | 58 (16.4) | 80 (16.1) | - | - | |
HWE p-value | 0.3200 | 0.5878 | |||
All peptic ulcer cases | |||||
Infected (n=86) | Uninfected (n=91) | ||||
GG | 58 (67.4) | 63 (69.2) | 0.7981 | 1.00 | - |
GA or AA | 28 (32.6) | 28 (30.8) | 1.09 | 0.57–2.06 | |
G | 144 (83.7) | 152 (83.5) | 0.9586 | - | - |
A | 28 (16.3) | 30 (16.7) | - | - | |
HWE p-value | 0.2066 | 0.9802 | |||
Female peptic ulcer case | |||||
Infected (n=54) | Uninfected (n=57) | ||||
GG | 33 (61.1) | 42 (73.7) | 0.1573 | 1.00 | - |
GA or AA | 21 (38.9) | 15 (25.3) | 1.78 | 0.59–5.39 | |
G | 87 (80.6) | 98 (86.0) | 0.2797 | - | - |
A | 21 (19.4) | 16 (14.0) | - | - | |
HWE p-value | 0.2171 | 1.000 | |||
Male peptic ulcer case | |||||
Infected (n=32) | Uninfected (n=34) | ||||
GG | 25 (78.1) | 21 (61.8) | 0.1515 | 1.00 | - |
GA or AA | 7 (21.9) | 13 (38.2) | 0.45 | 0.02–10.22 | |
G | 57 (89.1) | 54 (79.4) | 0.1312 | - | - |
A | 7 (10.9) | 14 (20.6) | - | - | |
HWE p-value | 0.9200 | 0.9556 |
Comparison of the
Peptic ulcer case (n=177) | Healthy individual (n=248) | p-value | OR | 95% CI | |
---|---|---|---|---|---|
TT | 113 (63.8) | 167 (67.3) | 0. 9663 | 1.00 | - |
CT | 61 (34.5) | 76 (30.6) | 1.02 | 0.98–1.53 | |
CC | 3 (1.7) | 5 (2.0) | 1.04 | 0.46–2.35 | |
T | 287 (81.1) | 410 (82.7) | 0.5525 | - | - |
C | 67 (18.9) | 86 (17.3) | - | - | |
HWE p-value | 0.2622 | 0.6228 | |||
All peptic ulcer case | |||||
Infected (n=86) | Uninfected (n=91) | ||||
TT | 54 (62.8) | 59 (64.8) | 0.7772 | 1.00 | - |
CT or CC | 32 (37.2) | 32 (35.2) | 1.09 | 0.59–2.03 | |
T | 139 (80.8) | 148 (81.3) | 0.9036 | - | - |
C | 33 (19.2) | 34 (18.7) | - | - | |
HWE p-value | 0.3684 | 0.7816 | |||
Female peptic ulcer case | |||||
Infected (n=54) | Uninfected (n=57) | ||||
TT | 33 (61.1) | 35 (61.4) | 0.9748 | 1.00 | - |
CT or CC | 21 (38.9) | 22 (38.6) | 1.09 | 0.59–2.03 | |
T | 86 (79.6) | 96 (79.8) | 0.2797 | - | - |
C | 22 (20.4) | 23 (20.2) | - | - | |
HWE p-value | 0.6867 | 0.5982 | |||
Male peptic ulcer case | |||||
Infected (n=32) | Uninfected (n=34) | ||||
TT | 21 (65.6) | 24 (70.6) | 0.6653 | 1.00 | - |
CT or CC | 11 (34.4) | 10 (29.4) | 1.26 | 0.42–3.77 | |
T | 53 (82.8) | 57 (83.8) | 0.8762 | - | - |
C | 11 (17.2) | 11 (16.2) | - | - | |
HWE p-value | 0.4748 | 1.000 |
Gut Liver 2014; 8(6): 632-636
Published online November 29, 2014 https://doi.org/10.5009/gnl13224
Copyright © Gut and Liver.
Aleksandra Sałagacka, Marta ?ebrowska, Agnieszka Jele?, Marek Mirowski, and Ewa Balcerczak
Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry, Medical University of Lodz, Lodz, Poland
Correspondence to: Aleksandra Sałagacka, Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland, Tel: +48-42-677-91-30, Fax: +48-42-677-91-30, E-mail: aleksandra.salagacka@umed.lodz.pl
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Tumor necrosis factor α (TNF-α) encoded by
Gastric mucosa specimens obtained from 177 Polish peptic ulcer patients were used to conduct rapid urease tests and to assess the investigated polymorphisms by polymerase chain reaction-restriction fragment length polymorphism. Genotyping data were compared with the results obtained from healthy individuals of Polish origin.
There were no significant differences in genotype and allele frequency of the investigated polymorphisms between peptic ulcer patients and healthy individuals. No associations between the frequencies of particular genotypes and alleles for both single-nucleotide polymorphisms (SNPs) and the presence of
The investigated SNPs are not risk factors for either peptic ulcer or
Keywords: Tumor necrosis factor-alpha, Genetic polymorphism, Peptic ulcer, Restriction fragment length polymorphism
Considering the vital role of TNF-α in the pathogenesis of PUD, it is reasonable to expect that genetic polymorphisms influencing the
The investigation was in accordance with the principles of the Declaration of Helsinki and was approved by the Ethical Committee of Medical University of Lodz. One hundred seventy-seven unrelated outpatients (111 females: median age 53 years, range 14 to 85 years; 66 males: median age 55 years, range 20 to 84 years) who visited the Department of Surgery, District Hospital, Łęczyca, Poland for an gastroduodenoscopy because of dyspepsia and diagnosed as peptic ulcer were enrolled in the study. Presence of
Genotyping of -308G>A and -1031T>C
Statistical analysis were performed using the STATISTICA version 10 (StatSoft Inc., Tulsa, OK, USA) software package. The chi-square test was applied to evaluate conformity between the observed and expected genotype frequencies according to the Hardy-Weinberg rule and to determine the significance of differences in allele and genotype frequencies between the patients and controls. An odds ratio with a 95% confidence interval was estimated by logistic regression. A p-value <0.05 was assumed as significant in all the conducted tests.
All 177 gastric mucosa biopsy specimens were successfully analysed for polymorphisms at positions -308 and -1031 of
All the genotypes for both polymorphisms were distributed in accordance with Hardy-Weinberg equilibrium within both patient and control cohorts which confirmed the cohorts as suitable. Genotype and allele frequencies occurred with similar frequencies in peptic ulcer and control groups for both -308G>A and -1031T>C SNPs. No statistically significant differences between investigated and control group were found (
According to the results of rapid urease tests, peptic ulcer patients were divided into two groups:
Host response to
The present study evaluated the effect of
There was no association between occurrence of peptic ulcer and any of investigated polymorphisms. This finding is in agreement with some of previously published results for peptic ulcer patients. No association was stated between PUD incidence and -308G>A
Also, there was no connection between any of investigated SNPs and
Recently, we showed that 3435C>T polymorphism of the
Some researchers postulate the
In conclusion, neither -308G>T nor -1031T>C SNP is a factor for genetic susceptibility to peptic ulcer in the population. Moreover, none of the investigated SNPs are the risk factors for
Table 1 Comparison of the
Peptic ulcer case (n=177) | Healthy individual (n=248) | p-value | OR | 95% CI | |
---|---|---|---|---|---|
GG | 121 (68.4) | 172 (69.4) | 0.8775 | 1.00 | - |
GA | 54 (30.5) | 72 (29.0) | 1.02 | 0.98–1.53 | |
AA | 2 (1.1) | 4 (1.6) | 1.04 | 0.46–2.35 | |
G | 296 (83.6) | 416 (83.9) | 0.9208 | - | - |
A | 58 (16.4) | 80 (16.1) | - | - | |
HWE p-value | 0.3200 | 0.5878 | |||
All peptic ulcer cases | |||||
Infected (n=86) | Uninfected (n=91) | ||||
GG | 58 (67.4) | 63 (69.2) | 0.7981 | 1.00 | - |
GA or AA | 28 (32.6) | 28 (30.8) | 1.09 | 0.57–2.06 | |
G | 144 (83.7) | 152 (83.5) | 0.9586 | - | - |
A | 28 (16.3) | 30 (16.7) | - | - | |
HWE p-value | 0.2066 | 0.9802 | |||
Female peptic ulcer case | |||||
Infected (n=54) | Uninfected (n=57) | ||||
GG | 33 (61.1) | 42 (73.7) | 0.1573 | 1.00 | - |
GA or AA | 21 (38.9) | 15 (25.3) | 1.78 | 0.59–5.39 | |
G | 87 (80.6) | 98 (86.0) | 0.2797 | - | - |
A | 21 (19.4) | 16 (14.0) | - | - | |
HWE p-value | 0.2171 | 1.000 | |||
Male peptic ulcer case | |||||
Infected (n=32) | Uninfected (n=34) | ||||
GG | 25 (78.1) | 21 (61.8) | 0.1515 | 1.00 | - |
GA or AA | 7 (21.9) | 13 (38.2) | 0.45 | 0.02–10.22 | |
G | 57 (89.1) | 54 (79.4) | 0.1312 | - | - |
A | 7 (10.9) | 14 (20.6) | - | - | |
HWE p-value | 0.9200 | 0.9556 |
Values are presented as number (%).
OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium.
Table 2 Comparison of the
Peptic ulcer case (n=177) | Healthy individual (n=248) | p-value | OR | 95% CI | |
---|---|---|---|---|---|
TT | 113 (63.8) | 167 (67.3) | 0. 9663 | 1.00 | - |
CT | 61 (34.5) | 76 (30.6) | 1.02 | 0.98–1.53 | |
CC | 3 (1.7) | 5 (2.0) | 1.04 | 0.46–2.35 | |
T | 287 (81.1) | 410 (82.7) | 0.5525 | - | - |
C | 67 (18.9) | 86 (17.3) | - | - | |
HWE p-value | 0.2622 | 0.6228 | |||
All peptic ulcer case | |||||
Infected (n=86) | Uninfected (n=91) | ||||
TT | 54 (62.8) | 59 (64.8) | 0.7772 | 1.00 | - |
CT or CC | 32 (37.2) | 32 (35.2) | 1.09 | 0.59–2.03 | |
T | 139 (80.8) | 148 (81.3) | 0.9036 | - | - |
C | 33 (19.2) | 34 (18.7) | - | - | |
HWE p-value | 0.3684 | 0.7816 | |||
Female peptic ulcer case | |||||
Infected (n=54) | Uninfected (n=57) | ||||
TT | 33 (61.1) | 35 (61.4) | 0.9748 | 1.00 | - |
CT or CC | 21 (38.9) | 22 (38.6) | 1.09 | 0.59–2.03 | |
T | 86 (79.6) | 96 (79.8) | 0.2797 | - | - |
C | 22 (20.4) | 23 (20.2) | - | - | |
HWE p-value | 0.6867 | 0.5982 | |||
Male peptic ulcer case | |||||
Infected (n=32) | Uninfected (n=34) | ||||
TT | 21 (65.6) | 24 (70.6) | 0.6653 | 1.00 | - |
CT or CC | 11 (34.4) | 10 (29.4) | 1.26 | 0.42–3.77 | |
T | 53 (82.8) | 57 (83.8) | 0.8762 | - | - |
C | 11 (17.2) | 11 (16.2) | - | - | |
HWE p-value | 0.4748 | 1.000 |
Values are presented as number (%).
OR, odds ratio; CI, confidence interval; HWE, Hardy-Weinberg equilibrium.